HCAT Insider Trading Activity and SEC Form 4 Filings
HCAT insider trading summary
Over the past 12 months, insiders at Health Catalyst, Inc. (HCAT) reported 2 sales worth $201K by 2 insiders and 1 open-market purchase worth $105K by 1 insider on SEC Form 4. Net insider selling was $95K.
Latest HCAT insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 14, 2026 | Simeon Kohl | Chief Executive Officer | Buy | $105K (59,000 @ $1.79) |
| Dec 5, 2025 | Benjamin Landry | General Counsel | Sell | $72K (27,425 @ $2.64) |
| Dec 4, 2025 | Julie Larson-Green | Insider | Sell | $128K (47,997 @ $2.67) |
| Sep 5, 2025 | Benjamin Landry | General Counsel | Sell | $21K (6,175 @ $3.35) |
| Jun 5, 2025 | Benjamin Landry | General Counsel | Sell | $24K (6,057 @ $3.94) |
| May 5, 2025 | Daniel LeSueur | Chief Operating Officer | Sell | $21K (5,209 @ $4.10) |
| Apr 3, 2025 | Daniel LeSueur | Chief Operating Officer | Sell | $22K (5,209 @ $4.15) |
| Mar 6, 2025 | Benjamin Landry | General Counsel | Sell | $63K (13,827 @ $4.55) |
| Mar 5, 2025 | Daniel LeSueur | Chief Operating Officer | Sell | $76K (16,902 @ $4.52) |
| Feb 18, 2025 | Linda Llewelyn | Chief People Officer | Sell | $35K (6,441 @ $5.43) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.